« Return to News | CROs/Service Providers

Cliantha Research selects Acceliant for trial data management

Wednesday, February 27, 2013 10:29 AM

Acceliant, a global technology provider of clinical trial data management solutions, has been chosen by Cliantha Research, a global CRO, to provide its eClinical Suite for Cliantha’s clinical trial data management needs. Acceliant's integrated e-PRO system offers a superior solution by allowing all the study data to be readily available, eliminating the integration costs.

"We evaluated and selected Acceliant eClinical Suite because we found it to be very user-friendly and superior to several other products,” said Hitesh Chauhan, associate director of biometrics, Cliantha Research. “Besides being a platform with best-in-class features, Acceliant's eClinical Suite is architected process and system wise to drive efficiency, lower costs and accelerate clinical trial studies."

Ven Thangaraj, CTO of Acceliant, said, "The life sciences industry is going through dramatic changes and pressures to innovate while keeping costs under control. Acceliant is one of the few integrated EDC-ePRO platforms with innovative workflows and built-in mobility which allows data management from anywhere, anytime."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.